Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 205,295 | 39,079 | 41,930 | 30,929 | 21,013 |
| Marketable Securities | N/A | 7,379 | 43,244 | 942 | 10,141 |
| Receivables | 3,164 | N/A | N/A | N/A | N/A |
| Inventories | 2,399 | N/A | N/A | N/A | N/A |
| TOTAL | $212,951 | $47,746 | $86,955 | $33,820 | $33,372 |
| Non-Current Assets | |||||
| PPE Net | 1,316 | 1,758 | 1,346 | 1,860 | 1,111 |
| Investments And Advances | 0 | 0 | 7,979 | 0 | 0 |
| Intangibles | 11,017 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 430 | 430 | 580 | 580 | 1,270 |
| TOTAL | $12,763 | $2,188 | $9,905 | $2,440 | $2,381 |
| Total Assets | $225,714 | $49,934 | $96,861 | $36,260 | $35,753 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 143 |
| Accounts payable and accrued liabilities | 2,424 | 512 | 2,988 | 2,783 | 2,255 |
| Accrued Expenses | 2,321 | 2,898 | 9,790 | 6,323 | 2,528 |
| TOTAL | $31,534 | $3,411 | $12,778 | $9,106 | $5,064 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 26,789 | N/A | N/A | N/A | 138 |
| TOTAL | $171,149 | $503 | $354 | $397 | $24 |
| Total Liabilities | $202,683 | $3,914 | $13,132 | $9,503 | $5,088 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,860 | 26,653 | 26,653 | 26,548 | N/A |
| Common Shares | 28 | 27 | 27 | 22 | 0 |
| Retained earnings | -260,833 | -224,975 | -173,910 | -99,841 | -36,329 |
| Other shareholders' equity | 0 | -20 | 12 | -3 | -18,784 |
| TOTAL | $23,031 | $46,020 | $83,729 | $26,757 | $30,665 |
| Total Liabilities And Equity | $225,714 | $49,934 | $96,861 | $36,260 | $35,753 |